Ophthalmology

RXi Pharmaceuticals, biotechnology company headquartered in Westborough, Mass., has announced it will present its work on the use of its sd-rxRNAs in retinoblastoma and proliferative vitreoretinopathy therapies at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.

IRIDEX, Mountain View, Calif.-based laser-based medical systems development company, has announced the recent sale of over $500,000 of its laser systems designed to treat eye conditions to the Brazilian, Russian, Chinese and Indian markets.

InSite Vision, Alameda, Calif.-based ophthalmological products company, has announced that it will be presenting five sponsored posters at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.

Palmetto Eye & Laser Center in Spartanburg, S.C., has acquired the Alcon WaveLight Refractive suite to offer its patients LASIK procedures, according to a Go Upstate report.

This spring, Phillips Eye & Surgery Center in Flemington, N.J., will hold an exhibit of artwork from Hunterdon Regional High School and Hunterdon Watercolor Society, according to an NJ.com report.

R-Tech Ueno, Japanese pharmaceutical company, has filed for and received FDA IND approval to begin Phase I and II clinical trials of its severe dry eye treatment, RU -101.

Pharm-Olam International, contract research organization for InSite Vision, has completed a Phase 3 clinical trial of BromSite, an anti-inflammatory designed to reduce swelling and pain after cataract surgery.

A three-year study led by Andrew Lotery, MD, ophthalmologist and professor at Southampton General Hospital in the U.K., has found that 65 percent of liver transplant patients developed age-related macular degeneration within five years of receiving the transplant, according to…

The American Academy of Ophthalmology "Want Scary Eyes?" campaign was launched in 2011 to promote consumer awareness of the dangers of using non-prescription decorative contact lens and has featured over 1,500 news stories and several audio news releases.

Lausanne, Switzerland-based Sensimed AG has announced that it will be presenting its Sensimed Triggerfish at the Association for Research in Vision and Ophthalmology 2013 meeting.